Under one in 10 individuals eligible to benefit from weight-loss injections such as Wegovy have access to them, states the global health agency as it issues its inaugural guidance on the therapies.
Considering in excess of 1,000,000,000 people worldwide now living with obesity, it is urging more widespread and fairer access to this class of drugs.
Per projections, in excess of 2,000,000,000 could be living with obesity by 2030 without intervention.
"Our new guidance recognises that excess weight is a lifelong illness that can be addressed with thorough and ongoing treatment," stated WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and logistical bottlenecks are significant hurdles to universal access to the treatments that can help people shift considerable weight, explains the organization.
Even in the present best projected scenario, the manufacturing of these medications could only cover approximately 100 million people – fewer than 10% of eligible patients, according to the WHO.
The guideline encourages nations and manufacturers to widen access, through approaches including voluntary licensing.
The intellectual property rights on semaglutide – the primary ingredient of a leading brand – is scheduled to end in several nations in 2026.
GLP-1 drugs imitate a biological compound to reduce digestion speed, curb appetite and increase the sense of being full so people reduce food intake.
People commonly start to lose weight after several weeks of starting on the weekly injections.
Research points to patients may see weight return a year later of halting the drug, as their typical food cravings resume.
To be above a healthy weight raises your likelihood for developing health problems, including type 2 diabetes, heart disease, stroke, and some malignancies.
Excess weight affects people in all nations and was associated with 3.7 million fatalities worldwide in 2024, as per the health agency.
Oliver Sterling is a seasoned sports betting analyst with over a decade of experience in the UK gambling industry.